Cargando…
Translating Academic Drug Discovery Into Clinical Development: A Survey of the Awareness of Regulatory Support and Requirements Among Stakeholders in Europe
Important discoveries by academic drug developers hold the promise of bringing innovative treatments that address unmet medical needs to the market. However, the drug development process has proved to be challenging and demanding for academic researchers, and regulatory challenges are an important b...
Autores principales: | Kallio, Marko J., Starokozhko, Viktoriia, Agricola, Eleonora, Burggraf, Manja, Heß, Anne, Ballensiefen, Wolfgang, Löbker, Wiebke, Nuevo, Yoana, Pasmooij, Anna M.G., Mol, Peter G.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099080/ https://www.ncbi.nlm.nih.gov/pubmed/36326573 http://dx.doi.org/10.1002/cpt.2789 |
Ejemplares similares
-
Biomarker Qualification at the European Medicines Agency: A Review of Biomarker Qualification Procedures From 2008 to 2020
por: Bakker, Elisabeth, et al.
Publicado: (2022) -
Contribution of Real‐World Evidence in European Medicines Agency's Regulatory Decision Making
por: Bakker, Elisabeth, et al.
Publicado: (2022) -
Precision medicine in regulatory decision making: Biomarkers used for patient selection in European Public Assessment Reports from 2018 to 2020
por: Bakker, Elisabeth, et al.
Publicado: (2023) -
Medication Adherence Measurement Methods in Registration Trials Supporting the Approval of New Medicines: A Cross‐Sectional Analysis of Centralized Procedures in the European Union 2010–2020
por: Mantila, Katerina M., et al.
Publicado: (2022) -
Attention for sex in COVID-19 trials: a review of regulatory dossiers
por: de Vries, Sieta T, et al.
Publicado: (2022)